Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/27489
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChartres, N-
dc.contributor.authorSass, JB-
dc.contributor.authorGee, D-
dc.contributor.authorBălan, SA-
dc.contributor.authorBirnbaum, L-
dc.contributor.authorCogliano, VJ-
dc.contributor.authorCooper, C-
dc.contributor.authorFedinick, KP-
dc.contributor.authorHarrison, RM-
dc.contributor.authorKolossa‑Gehring, M-
dc.contributor.authorMandrioli, D-
dc.contributor.authorMitchell, MA-
dc.contributor.authorNorris, SL-
dc.contributor.authorPortier, CJ-
dc.contributor.authorStraif, K-
dc.contributor.authorVermeire, T-
dc.date.accessioned2023-10-31T18:14:18Z-
dc.date.available2023-10-31T18:14:18Z-
dc.date.issued2022-12-05-
dc.identifier123-
dc.identifier.citationChartres, N. et al. (2022) 'Conducting evaluations of evidence that are transparent, timely and can lead to health-protective actions', Environmental Health, 21, 123, pp. 1 - 23.. doi: 10.1186/s12940-022-00926-z.en_US
dc.identifier.urihttps://bura.brunel.ac.uk/handle/2438/27489-
dc.descriptionAvailability of data and materials: No new data was generated for this paper; only existing, publicly available data were used. DOIs and hyperlinks are included throughout the literature cited.en_US
dc.descriptionContributions: Under the leadership of NC, JBS, and DG, all authors contributed to the February 2021 Workshop on Conducting Evaluations of Evidence that are Transparent, Timely and Lead to Health-Protective Actions (see Workshop Robust Proceedings here: https://prhe.ucsf.edu/sites/g/files/tkssra341/f/wysiwyg/Proceedings_Final_05_10.pdf). Thereafter, those authors included here have expanded their participation by contributing substantively to this manuscript. The author(s) read and approved the final manuscript.-
dc.description.abstractCopyright © The Author(s) 2022. Background: In February 2021, over one hundred scientists and policy experts participated in a web-based Workshop to discuss the ways that divergent evaluations of evidence and scientific uncertainties are used to delay timely protection of human health and the environment from exposures to hazardous agents. The Workshop arose from a previous workshop organized by the European Environment Agency (EEA) in 2008 and which also drew on case studies from the EEA reports on ‘Late Lessons from Early Warnings’ (2001, 2013). These reports documented dozens of hazardous agents including many chemicals, for which risk reduction measures were delayed for decades after scientists and others had issued early and later warnings about the harm likely to be caused by those agents. Results: Workshop participants used recent case studies including Perfluorooctanoic acid (PFOA), Extremely Low Frequency – Electrical Magnetic Fields (ELF-EMF fields), glyphosate, and Bisphenol A (BPA) to explore myriad reasons for divergent outcomes of evaluations, which has led to delayed and inadequate protection of the public’s health. Strategies to overcome these barriers must, therefore, at a minimum include approaches that 1) Make better use of existing data and information, 2) Ensure timeliness, 3) Increase transparency, consistency and minimize bias in evidence evaluations, and 4) Minimize the influence of financial conflicts of interest. Conclusion: The recommendations should enhance the production of “actionable evidence,” that is, reliable evaluations of the scientific evidence to support timely actions to protect health and environments from exposures to hazardous agents. The recommendations are applicable to policy and regulatory settings at the local, state, federal and international levels.en_US
dc.description.sponsorshipNC & CC contribution to this manuscript was supported by JPB Foundation (grant 681). JBS gratefully acknowledges funding support from the Passport Foundation.en_US
dc.format.extent1 - 23-
dc.format.mediumElectronic-
dc.language.isoen_USen_US
dc.publisherBiomed Central (part of Springer Nature)en_US
dc.rightsCopyright © The Author(s) 2022. Rights and permissions: Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subjectconflicts of interesten_US
dc.subjectindustry sponsorshipen_US
dc.subjectenvironmental justiceen_US
dc.subjectcumulative impactsen_US
dc.subjectnon-chemical stressorsen_US
dc.subjectprecautionary principleen_US
dc.subjectrisk of biasen_US
dc.subjectsystematic reviewen_US
dc.subjecttransparencyen_US
dc.titleConducting evaluations of evidence that are transparent, timely and can lead to health‑protective actionsen_US
dc.typeArticleen_US
dc.identifier.doihttps://doi.org/10.1186/s12940-022-00926-z-
pubs.volume21-
dc.rights.holderThe Author(s)-
Appears in Collections:Dept of Health Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdf1.5 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons